SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-044116
Filing Date
2012-08-09
Accepted
2012-08-09 17:00:30
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v319101_10q.htm 10-Q 291799
2 EXHIBIT 31.1 v319101_ex31-1.htm EX-31.1 8262
3 EXHIBIT 31.2 v319101_ex31-2.htm EX-31.2 8323
4 EXHIBIT 32.1 v319101_ex32-1.htm EX-32.1 3823
5 EXHIBIT 32.2 v319101_ex32-2.htm EX-32.2 3717
  Complete submission text file 0001144204-12-044116.txt   2350502

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtus-20120630.xml EX-101.INS 206315
7 XBRL TAXONOMY EXTENSION SCHEMA vtus-20120630.xsd EX-101.SCH 35915
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtus-20120630_cal.xml EX-101.CAL 27009
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtus-20120630_def.xml EX-101.DEF 168304
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtus-20120630_lab.xml EX-101.LAB 269521
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtus-20120630_pre.xml EX-101.PRE 195978
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
VENTRUS BIOSCIENCES INC (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 121021114
SIC: 2834 Pharmaceutical Preparations